Pages

Monday, January 23, 2012

Target the Fight Against Cancer

As research continues to advance our understanding of cancer, there’s now a new way for doctors to take better aim in the care of their cancer patients. Caris Target Now™  is an evidence-based molecular profiling technology that can help determine which cancer therapies are more likely to be effective and which therapies are likely to be ineffective.

Why is Caris Target Now™ important?  No two cancers are alike and cancer treatment plans shouldn’t be either. Treatment that works well for one person may be ineffective for another, because each patient’s cancer has different genetics.  Caris Target Now™ makes it possible to detect those differences, match a tumor’s genetics with specific drugs more likely to be effective, and flag therapies with less chance of working. Personalized cancer treatment like this can increase quality of life, uncover treatments previously not considered, and cut healthcare costs. One multicenter study conducted by Caris™ Life Sciences, and published in the Journal of Clinical Oncology, showed that Caris Target Now™ molecular profiling increased progression free survival from various cancers, including late-stage cancer, in 27 percent of 86 patients studied who had their therapy selected this way, versus the previous therapy on which they progressed.

Interested in learning more from an expert?  Watch as Sandeep K. Reddy, MD, oncology expert and clinical associate professor of medicine, Geffen/UCLA School of Medicine, discusses Caris Target Now™, and as Sandra Fehrman, a cancer patient, explains how this technology helped to extend and enhance her life, in this moving video.

All opinions expressed in this review are my own and not influenced in any way by the company.  Any product claim, statistic, quote or other representation about a product or service should be verified with the manufacturer or provider. Please refer to this site's Disclaimer  for more information. I have been compensated or given a product free of charge, but that does not impact my views or opinions.

-------------------------------------------------------------------------
New to the Divadom or to Dad of Divas Reviews?
Please Subscribe to my RSS Feed! Subscribe in a reader
Questions?Drop me a line at dadofdivas@gmail.com

No comments:

Post a Comment